4/A: FRACTYL HEALTH, INC.: Director Samuel Conaway Corrects Erroneous Form 4 Filing

Samuel Conaway, a director of FRACTYL HEALTH, INC., files an amended Form 4 to correct a previous filing that mistakenly reported a purchase of common stock.

Summary

• This is an amended Form 4 filing by Samuel Conaway, a director of FRACTYL HEALTH, INC.
• The amendment corrects an error in a previous Form 4 filed on March 17, 2025, which incorrectly reported a purchase of 8,550 shares of common stock.
• The reporting person, Samuel Conaway, clarifies that the purchase did not occur and confirms that as of March 13, 2025, and the date of this filing, he does not own any shares of common stock in FRACTYL HEALTH, INC.

Sentiment

Score: 7

Explanation: The document is a routine correction of a filing error, indicating a neutral sentiment. It ensures accuracy and transparency, which is generally viewed positively.

Positives

• The correction of the erroneous filing ensures accurate information is available to investors.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, ensuring transparency in the market.

Stakeholder Impact

• The correction of the filing ensures that shareholders and potential investors have accurate information regarding insider ownership.

Key Dates